Fig. 5
From: miR-486-5p predicted adverse outcomes of SCAP and regulated K. pneumonia infection via FOXO1
K. pneumonia suppressed proliferation (a) and enhanced TNF-alpha (b), IL-6 (c), and IL-1beta (d) levels, which was alleviated by miR-486-5p knockdown. Silencing FOXO1 could reverse the attenuated effect of miR-486-5p on K. pneumonia-treated ACEII cells. *P < 0.05, **P < 0.01, ***P < 0.001